The Corona vaccine Sputnik V is 92 percent effective in humans, Russia claims. The vaccine is  in Phase 3 clinical trials. Trials are underway in Belarus, the United Arab Emirates and Venezuela. Besides, the second and third round trials are going on in India. Of these, 92 percent effectiveness of the vaccine was claimed. 10,000 people in Russia take the vaccine. On that basis, Russia claims that its effectiveness has been proven in 90 percent of the body.

That said, no physical problems were seen in anyone after the experimental application. However, this is a preliminary report. This report was given 21 days after the vaccination. With a little more time, clear results will be known.

In August, Russia claimed the effectiveness of the Sputnik V-Ticker as the first country in the world. At the time, it was said, it would be quickly brought to market for common use. So will this vaccine come to the Indian market quickly? The government did not say anything. Recently, the Pfizer vaccine has been claimed to be 90 percent effective. The Union Ministry of Health has since said that the center is in regular contact with coroner vaccine research companies around the world.


However, Russia's ticker trial is not over yet. It will take another six months to complete the trial. According to the Russian Direct Investment Fund, all the information from the trial will be published in the world's leading medical research paper. Then it will be known more clearly. According to the news agency, President Putin also expressed confidence in the vaccine. He said that that the study shows that effectiveness of the vaccine is considerable . No side effects have been reported in the human body. "